Lastly, given our finding that rectal cancer patients with positive SLS LC3A staining in the TP have worse OS than patients with negative for this staining pattern, we performed Kaplan–Meier survival analysis for patients who were grouped by tumor stage (T1–T2 vs. T3–T4). The gene discussed is MAP1LC3A; the disease is rectal cancer.